| __timestamp | Amneal Pharmaceuticals, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 4534000000 |
| Thursday, January 1, 2015 | 136870000 | 5920000000 |
| Friday, January 1, 2016 | 204747000 | 4940000000 |
| Sunday, January 1, 2017 | 191938000 | 6411000000 |
| Monday, January 1, 2018 | 210451000 | 6345000000 |
| Tuesday, January 1, 2019 | 202287000 | 6148000000 |
| Wednesday, January 1, 2020 | 190585000 | 11143000000 |
| Friday, January 1, 2021 | 209563000 | 10195000000 |
| Saturday, January 1, 2022 | 200046000 | 9509000000 |
| Sunday, January 1, 2023 | 167778000 | 9299000000 |
| Monday, January 1, 2024 | 11159000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, innovation is key. Bristol-Myers Squibb Company and Amneal Pharmaceuticals, Inc. have been investing in research and development (R&D) to stay ahead. From 2014 to 2023, Bristol-Myers Squibb consistently outpaced Amneal, investing nearly 40 times more in R&D on average. In 2020, Bristol-Myers Squibb peaked with an investment of approximately $11 billion, a 150% increase from 2014. Meanwhile, Amneal's R&D spending remained relatively stable, with a slight increase of about 57% over the same period. This disparity highlights Bristol-Myers Squibb's aggressive strategy to lead in innovation, while Amneal maintains a more conservative approach. As the pharmaceutical landscape evolves, these investment trends could significantly impact each company's future market position.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and argenx SE
Bristol-Myers Squibb Company or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Rhythm Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
R&D Insights: How argenx SE and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Biogen Inc. vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: United Therapeutics Corporation vs Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.